These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6631522)

  • 1. Effect of doxorubicin on [omega-I-131]heptadecanoic acid myocardial scintigraphy and echocardiography in dogs.
    Styles CB; Noujaim AA; Jugdutt BI; Sykes TR; Bain GO; Shnitka TK; Hooper HR
    J Nucl Med; 1983 Nov; 24(11):1012-8. PubMed ID: 6631522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes.
    Working PK; Newman MS; Sullivan T; Yarrington J
    J Pharmacol Exp Ther; 1999 May; 289(2):1128-33. PubMed ID: 10215696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment with ICRF-187 allows a marked increase in the total cumulative dose of doxorubicin tolerated by beagle dogs.
    Herman EH; Ferrans VJ; Young RS; Hamlin RL
    Drugs Exp Clin Res; 1988; 14(9):563-70. PubMed ID: 3147886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of mitoxantrone treatment in beagle dogs previously treated with minimally cardiotoxic doses of doxorubicin.
    Tham P; Dougherty W; Iatropoulos MJ; Gordon G; James VC; Hall C; Noble JF
    Am J Pathol; 1987 Jul; 128(1):121-30. PubMed ID: 3605309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical study on the protective potential of Nardostachys jatamansi extract on lipid profile and lipid metabolizing enzymes in doxorubicin intoxicated rats.
    Subashini R; Ragavendran B; Gnanapragasam A; Yogeeta SK; Devaki T
    Pharmazie; 2007 May; 62(5):382-7. PubMed ID: 17557749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive molecular imaging of apoptosis in a mouse model of anthracycline-induced cardiotoxicity.
    Su H; Gorodny N; Gomez LF; Gangadharmath U; Mu F; Chen G; Walsh JC; Szardenings K; Kolb HC; Tamarappoo B
    Circ Cardiovasc Imaging; 2015 Feb; 8(2):e001952. PubMed ID: 25657296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety assessment of new anticancer compound, mitoxantrone, in beagle dogs: comparison with doxorubicin. II. Histologic and ultrastructural pathology.
    Sparano BM; Gordon G; Hall C; Iatropoulos MJ; Noble JF
    Cancer Treat Rep; 1982 May; 66(5):1145-58. PubMed ID: 7083217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pretreatment with ICRF-187 on the total cumulative dose of doxorubicin tolerated by beagle dogs.
    Herman EH; Ferrans VJ; Young RS; Hamlin RL
    Cancer Res; 1988 Dec; 48(23):6918-25. PubMed ID: 3141049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectants.
    Van Vleet JF; Ferrans VJ; Weirich WE
    Am J Pathol; 1980 Apr; 99(1):13-42. PubMed ID: 7361854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baicalein alleviates doxorubicin-induced cardiotoxicity via suppression of myocardial oxidative stress and apoptosis in mice.
    Sahu BD; Kumar JM; Kuncha M; Borkar RM; Srinivas R; Sistla R
    Life Sci; 2016 Jan; 144():8-18. PubMed ID: 26606860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of octreotide in the prevention of doxorubicin cardiotoxicity.
    Barçin C; Kurşaklioğlu H; Safali M; Iyisoy A; Köse SB; Barindik N; Işik E
    Anadolu Kardiyol Derg; 2005 Mar; 5(1):18-23. PubMed ID: 15755696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin affects both the number and the morphology of specific atrial granules in dog heart.
    Bellini O; Danesi R; Bernardini N; Cardini G; Marzilli M; del Tacca M
    Anticancer Res; 1988; 8(4):599-604. PubMed ID: 3178151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats.
    Fadillioglu E; Oztas E; Erdogan H; Yagmurca M; Sogut S; Ucar M; Irmak MK
    J Appl Toxicol; 2004; 24(1):47-52. PubMed ID: 14745846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intravenous versus intraatrial administration of doxorubicin on the function and structure of the heart.
    Edington H; Mayer D; Au FC; Elfenbein IB; Bove AA; Smalley RV
    J Surg Oncol; 1984 Sep; 27(1):12-7. PubMed ID: 6482445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adriamycin cardiomyopathy: implications of cellular changes in a canine model with mild impairment of left ventricular function.
    Tomlinson CW; Godin DV; Rabkin SW
    Biochem Pharmacol; 1985 Nov; 34(22):4033-41. PubMed ID: 2998397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adriamycin-induced cardiac damage in the mouse: a small-animal model of cardiotoxicity.
    Rosenoff SH; Olson HM; Young DM; Bostick F; Young RC
    J Natl Cancer Inst; 1975 Jul; 55(1):191-4. PubMed ID: 1159813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin mediated cardiotoxicity in rats: protective role of felodipine on cardiac indices.
    Gandhi H; Patel VB; Mistry N; Patni N; Nandania J; Balaraman R
    Environ Toxicol Pharmacol; 2013 Nov; 36(3):787-95. PubMed ID: 23958971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive value of myocardial radioisotope scanning in animals treated with doxorubicin.
    Gorton SJ; Wilson GA; Sutherland R; Schenk E; Chacko AK; Durakovic A; Bennett JM
    J Nucl Med; 1980 Jun; 21(6):518-22. PubMed ID: 6247465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin-induced late cardiotoxicity: delayed impairment of Ca2+-handling mechanisms in the sarcoplasmic reticulum in the rat.
    Chugun A; Temma K; Oyamada T; Suzuki N; Kamiya Y; Hara Y; Sasaki T; Kondo H; Akera T
    Can J Physiol Pharmacol; 2000 Apr; 78(4):329-38. PubMed ID: 10772060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicity.
    El-Demerdash E; Ali AA; Sayed-Ahmed MM; Osman AM
    Cancer Chemother Pharmacol; 2003 Nov; 52(5):411-6. PubMed ID: 12879278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.